APA

Leinhase I., Schmidt O. I., Thurman J. M., Hossini A. M., Rozanski M., Taha M. E., Scheffler A., John T., Smith W. R., Holers V. M. & Stahel P. F. (20060811). Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. : Experimental neurology.

Chicago

Leinhase Iris, Schmidt Oliver I, Thurman Joshua M, Hossini Amir M, Rozanski Michal, Taha Mohy E, Scheffler Alice, John Thilo, Smith Wade R, Holers V Michael and Stahel Philip F. 20060811. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. : Experimental neurology.

Harvard

Leinhase I., Schmidt O. I., Thurman J. M., Hossini A. M., Rozanski M., Taha M. E., Scheffler A., John T., Smith W. R., Holers V. M. and Stahel P. F. (20060811). Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. : Experimental neurology.

MLA

Leinhase Iris, Schmidt Oliver I, Thurman Joshua M, Hossini Amir M, Rozanski Michal, Taha Mohy E, Scheffler Alice, John Thilo, Smith Wade R, Holers V Michael and Stahel Philip F. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. : Experimental neurology. 20060811.